Worthington Steel Shares Jump 15.7% After Beating Earnings Expectations

Worthington Steel shares surged 15.7% in pre-market trading after the company reported Q4 earnings of $1.05 per share, beating the analyst consensus estimate of 82 cents per share. Other stocks moving in pre-market trading include Vor Biopharma, Adial Pharmaceuticals, MKDWELL Tech, Baird Medical, KWESST Micro Systems, Beeline Holdings, Nano Labs, Altimmune, MillerKnoll, Reviva Pharmaceuticals, Globavend Holdings, ZyVersa Therapeutics, GlucoTrack, Wag!, XCF Global, and Portage Biotech.

Worthington Steel Inc. (WS) shares surged 15.7% in pre-market trading on June 26, 2025, following the company's announcement of its Q4 earnings. The company reported adjusted earnings per share (EPS) of $1.05, surpassing the analyst consensus estimate of 82 cents per share [1][2].

The stock opened at $31.66, gapping up from its previous close of $26.26, and last traded at $29.62 with a volume of 230,319 shares. This performance was driven by the company's strong earnings report, which also beat revenue expectations. Revenue fell 8.6% to $832.90 million compared to the same period last year, but this was still above the analyst estimate of $800.45 million [1][2][3].

The company's net margin was 3.41%, and its return on equity was 9.58%. The firm's quarterly revenue was down 8.6% compared to the same quarter last year. The business serves various end-markets, including automotive, heavy truck, agriculture, construction, and energy [3].

Institutional investors have been actively trading Worthington Steel shares. Proficio Capital Partners LLC, GAMMA Investing LLC, Handelsbanken Fonder AB, Harbor Capital Advisors Inc., and Charles Schwab Investment Management Inc. have all increased their stakes in the company's stock. The firm has a market capitalization of $1.50 billion, a PE ratio of 13.79, and a beta of 1.64 [3].

Other stocks moving in pre-market trading include Vor Biopharma Inc. (VOR), Adial Pharmaceuticals, Inc. (ADIL), MKDWELL Tech Inc. (MKDW), Baird Medical Investment Holdings Limited (BDMD), KWESST Micro Systems Inc. (KWE), Beeline Holdings, Inc. (BLNE), Nano Labs Ltd (NA), Altimmune, Inc. (ALT), MillerKnoll, Inc. (MLKN), Reviva Pharmaceuticals Holdings, Inc. (RVPH), Globavend Holdings Limited (GVH), ZyVersa Therapeutics, Inc. (ZVSA), GlucoTrack, Inc. (GCTK), Wag! Group Co. (PET), XCF Global, Inc. (SAFX), and Portage Biotech Inc. (PRTG) [2].

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3SS1NO:0-worthington-steel-inc-reports-results-for-the-quarter-ended-may-31-earnings-summary/
[2] https://www.benzinga.com/news/25/06/46110267/why-worthington-steel-shares-are-trading-higher-by-over-15-here-are-20-stocks-moving-premarket
[3] https://www.marketbeat.com/instant-alerts/worthington-steel-nysews-shares-gap-up-after-better-than-expected-earnings-2025-06-26/